We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $1.52B
1-Year Est. Return 229.41%
This Fund
S&P 500
This Quarter Est. Return
+23.47%
1 Year Est. Return
+229.41%
3 Year Est. Return
+810.62%
5 Year Est. Return
+1,830.01%
10 Year Est. Return
+67,312.86%
AUM
$558M
AUM Growth
+$37.6M
Cap. Flow
+$15.1M
Cap. Flow %
2.71%
Top 10 Hldgs %
33.83%
Holding
112
New
24
Increased
27
Reduced
29
Closed
27

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$6.49M
2
MOH icon
Molina Healthcare
MOH
+$6.13M
3
CNC icon
Centene
CNC
+$5.55M
4
DXCM icon
DexCom
DXCM
+$5.21M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$5.12M

Top Sells

Rank Stock Value
1
WW
WW International
WW
+$12.1M
2
ETSY icon
Etsy
ETSY
+$6.63M
3
ADSK icon
Autodesk
ADSK
+$5.08M
4
META icon
Meta Platforms (Facebook)
META
+$4.16M
5
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$4.15M

Sector Composition

Rank Sector Weight
1 Healthcare 37.06%
2 Miscellaneous 25.83%
3 Technology 14.91%
4 Communication Services 9.68%
5 Consumer Discretionary 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$80.3B
$42.1M 7.56%
+250,000
New +$42.2M
QQQ icon
2
PUT
Invesco QQQ Trust
QQQ
$491B
$27.9M 5%
150,000
-300,000
-67% -$54.3M
XBI icon
3
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.4B
$24M 4.3%
250,000
+50,000
+25% +$4.85M
DXCM icon
4
DexCom
DXCM
$31.9B
$16.7M 3%
468,000
+168,000
+56% +$5.21M
WWE
5
CALL
DELISTED
World Wrestling Entertainment
WWE
$15M 2.69%
155,000
– –
LIVN icon
6
CALL
LivaNova
LIVN
$4.43B
$14.6M 2.61%
+117,500
New +$13.9M
SRPT icon
7
Sarepta Therapeutics
SRPT
$2.14B
$12.8M 2.29%
79,000
+7,000
+10% +$957K
BATRK icon
8
Atlanta Braves Holdings Series B
BATRK
$3.24B
$12.2M 2.2%
449,456
-9,900
-2% -$258K
NFLX icon
9
Netflix
NFLX
$319B
$11.9M 2.13%
318,000
-7,000
-2% -$254K
TDOC icon
10
Teladoc Health
TDOC
$1.15B
$11.5M 2.06%
133,000
+54,000
+68% +$3.85M
MSFT icon
11
Microsoft
MSFT
$3.66T
$11.3M 2.03%
99,000
+9,000
+10% +$976K
AMZN icon
12
Amazon
AMZN
$2.77T
$11.3M 2.03%
113,000
-2,000
-2% -$188K
ISRG icon
13
Intuitive Surgical
ISRG
$123B
$11.1M 1.99%
57,900
+3,900
+7% +$693K
XYZ
14
Block Inc
XYZ
$48.3B
$10.4M 1.86%
105,000
+15,000
+17% +$1.16M
NVCR icon
15
NovoCure
NVCR
$2.03B
$10.3M 1.85%
197,000
+107,000
+119% +$4.26M
EXAS
16
DELISTED
Exact Sciences
EXAS
$9.87M 1.77%
125,000
+7,000
+6% +$456K
OKTA icon
17
Okta
OKTA
$29.3B
$9.71M 1.74%
138,000
+15,000
+12% +$893K
RNG icon
18
RingCentral
RNG
$5.9B
$9.21M 1.65%
99,000
-9,000
-8% -$777K
HUBS icon
19
HubSpot
HUBS
$12.2B
$9.06M 1.62%
60,000
-5,500
-8% -$756K
ROKU icon
20
Roku
ROKU
$23B
$8.33M 1.49%
114,000
-46,000
-29% -$2.63M
ARNA
21
DELISTED
Arena Pharmaceuticals Inc
ARNA
$8.28M 1.49%
180,000
-10,000
-5% -$405K
UNH icon
22
UnitedHealth
UNH
$355B
$7.93M 1.42%
29,800
+1,300
+5% +$338K
ALGN icon
23
Align Technology
ALGN
$10.9B
$7.82M 1.4%
20,000
-7,000
-26% -$2.58M
LKFT
24
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$7.32M 1.31%
65,100
+6,100
+10% +$644K
MOH icon
25
Molina Healthcare
MOH
$10.3B
$7.14M 1.28%
+48,000
New +$6.13M
1
2 3 4 5

Similar funds

ACM
Adelante Capital Management Alameda, California $1.52B AUM 23.15% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
MIM
Marco Investment Management Atlanta, Georgia $1.52B AUM 47.33% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.52B AUM 10.48% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return

Atika Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Atika Capital Management held 112 positions worth $558M, up 7.2% from $520M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Atika Capital Management's Q3 2018 filing shows 24 new, 27 increased, 29 reduced and 27 closed positions. Its largest new stake was Elevance Health: 25,000 shares worth $6.85M. The largest sale was WW International, an estimated $12.1M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 27% a quarter earlier, followed by Miscellaneous and Technology.

  • Atika Capital Management's largest Q3 2018 buy was Elevance Health: 25,000 shares worth $6.85M.
  • Atika Capital Management added most to DexCom in Q3 2018, an estimated $5.21M increase.
  • Atika Capital Management's biggest Q3 2018 reduction was Etsy, cutting an estimated $6.63M.
  • Atika Capital Management fully exited WW International in Q3 2018, selling an estimated $12.1M.
  • Atika Capital Management's ten largest holdings make up 34% of its $558M portfolio in Q3 2018.
  • Atika Capital Management opened 24 new positions and closed 27 in Q3 2018.
  • Atika Capital Management's portfolio value rose 7.2% quarter-over-quarter to $558M.

Based on Atika Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.